NOTE AMENDMENT AND RELEASE OF COLLATERALCardium Therapeutics, Inc. • July 21st, 2009 • Biological products, (no disgnostic substances)
This Note Amendment and Release of Collateral is made as of this 20th day of July, 2009 by and among Cardium Therapeutics, Inc., a Delaware corporation (the “Company”), and holders (each a “Holder”) of a senior subordinated secured promissory notes issued pursuant to the terms of that certain Note and Warrant Purchase Agreement dated February 27, 2009 (“Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Notes.
NOTE AMENDMENTNote Amendment • July 21st, 2009 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Note Amendment (this “Amendment”) is made as of this 20th day of July, 2009 by and among Cardium Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders (each a “Holder”) of an unsecured promissory note issued pursuant to the terms of that certain Note and Warrant Purchase Agreement dated June 11, 2009 (“Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Notes.
